Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
HCWB US​

HCW Biologics Inc.(HCWB US)

$1.17+0.054.46%Ext:$1.13-0.043.11%(Market Closed · 23:55:18 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

Financials(25)

Expand
  • 10-QQ2ended 30 Jun 202614 Aug
  • 10-Q/AQ1ended 31 Mar 202614 Aug
  • 10-QQ1ended 31 Mar 202614 May
  • 10-KFY 2025ended 31 Dec 202531 Mar
  • 10-QQ3ended 30 Sept 202514 Nov 2025
  • 10-QQ2ended 30 Jun 202518 Aug 2025
  • NT 10-QQ2ended 30 Jun 202515 Aug 2025
  • 10-QQ1ended 31 Mar 202515 May 2025
  • 10-KFY 2024ended 31 Dec 202428 Mar 2025
  • 10-QQ3ended 30 Sept 202414 Nov 2024
  • 10-QQ2ended 30 Jun 202414 Aug 2024
  • 10-QQ1ended 31 Mar 202415 May 2024
  • 10-K/AFY 2023ended 31 Dec 202315 May 2024
  • 10-KFY 2023ended 31 Dec 20231 Apr 2024
  • 10-QQ3ended 30 Sept 202314 Nov 2023

Events(98)

Expand
  • 8-KEntry into a Material Definitive Agreement24 Sep
  • 8-KRegulation FD Disclosure9 Sep
  • 8-KEntry into a Material Definitive Agreement8 Sep
  • 8-KResults of Operations and Financial Condition14 Aug
  • 8-KNon-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review14 Aug
  • 8-KEntry into a Material Definitive Agreement29 Jul
  • 8-KOther Events1 Jul
  • 8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing30 Jun
  • 8-KMaterial Modifications to Rights of Security Holders26 Jun
  • 8-KRegulation FD Disclosure16 Jun
  • 8-KSubmission of Matters to a Vote of Security Holders15 Jun
  • 8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing1 Jun
  • 8-KTermination of a Material Definitive Agreement27 May
  • 8-KEntry into a Material Definitive Agreement21 May
  • 8-KResults of Operations and Financial Condition14 May

Insider Ownership(109)

Expand
  • 4Statement of changes in beneficial ownership31 Jul
  • 4Statement of changes in beneficial ownership31 Jul
  • 4Statement of changes in beneficial ownership31 Jul
  • 4Statement of changes in beneficial ownership27 May
  • 4Statement of changes in beneficial ownership27 May
  • 4Byam Rebecca27 May
  • 4Statement of changes in beneficial ownership20 May 2025
  • 4Statement of changes in beneficial ownership20 May 2025
  • 4Statement of changes in beneficial ownership20 May 2025
  • 4Statement of changes in beneficial ownership9 May 2025
  • 4Statement of changes in beneficial ownership9 May 2025
  • 4Statement of changes in beneficial ownership9 May 2025
  • 4Statement of changes in beneficial ownership9 May 2025
  • 4Statement of changes in beneficial ownership9 May 2025
  • 4Statement of changes in beneficial ownership9 May 2025

Beneficial Ownership(5)

Expand
  • SC 13G/AHCW Biologics Inc.15 May
  • SC 13GHCW Biologics Inc.17 Feb
  • SC 13D/AHCW Biologics Inc.13 Jun 2025
  • SC 13D/AHCW Biologics Inc.22 Nov 2024
  • SC 13DHCW Biologics Inc.2 Aug 2021

Proxies(22)

Expand
  • DEF 14ADefinitive proxy statement1 Oct
  • PRER14APreliminary proxy statement (revision)9 Sep
  • PRE 14APreliminary proxy statement4 Sep
  • DEF 14ADefinitive proxy statement29 Apr
  • ARSAnnual report to security holders28 Apr
  • PRE 14APreliminary proxy statement17 Apr
  • DEF 14ADefinitive proxy statement13 Mar
  • PRE 14APreliminary proxy statement3 Mar
  • DEF 14ADefinitive proxy statement28 Apr 2025
  • DEFA14ADefinitive additional materials28 Apr 2025
  • ARSAnnual report to security holders28 Apr 2025
  • DEFR14ADefinitive revised proxy statement26 Feb 2025
  • DEF 14ADefinitive proxy statement21 Feb 2025
  • PRE 14APreliminary proxy statement11 Feb 2025
  • ARS/AAnnual report to security holders (amendment)20 May 2024

Registrations(37)

Expand
  • S-1Registration statement (general form)2 Oct
  • S-1/ARegistration statement (general form, amendment)28 Aug
  • S-1Registration statement (general form)20 Aug
  • POS AMPost-effective amendment (unspecified)16 Jul
  • S-1/ARegistration statement (general form, amendment)18 Jun
  • S-1Registration statement (general form)8 Jun
  • POS AMPost-effective amendment (unspecified)18 May
  • POS AMPost-effective amendment (unspecified)13 May
  • S-1/ARegistration statement (general form, amendment)24 Apr
  • S-1Registration statement (general form)23 Apr
  • DRSDraft registration statement10 Apr
  • 424B4Prospectus filing (Rule 424(b)(4))19 Feb
  • S-1/ARegistration statement (general form, amendment)17 Feb
  • S-1/ARegistration statement (general form, amendment)13 Feb
  • S-1Registration statement (general form)11 Feb

Filing Review Correspondence(17)

Expand
  • CORRESPFiling review correspondence28 Aug
  • CORRESPFiling review correspondence16 Jun
  • CORRESPFiling review correspondence11 Feb
  • CORRESPFiling review correspondence11 Feb
  • CORRESPFiling review correspondence27 Jan
  • CORRESPFiling review correspondence13 May 2025
  • CORRESPFiling review correspondence9 May 2025
  • CORRESPFiling review correspondence15 Apr 2025
  • CORRESPFiling review correspondence25 Aug 2022
  • CORRESPFiling review correspondence16 Jul 2021
  • CORRESPFiling review correspondence16 Jul 2021
  • CORRESPFiling review correspondence15 Jul 2021
  • CORRESPFiling review correspondence13 Jul 2021
  • CORRESPFiling review correspondence13 Jul 2021
  • CORRESPFiling review correspondence15 Jun 2021

SEC Orders And Notices(11)

Expand
  • EFFECTNotice of effectiveness13 Oct
  • EFFECTNotice of effectiveness1 Sep
  • EFFECTNotice of effectiveness22 Jun
  • EFFECTNotice of effectiveness30 Apr
  • EFFECTNotice of effectiveness18 Feb
  • EFFECTNotice of effectiveness30 Jan
  • EFFECTNotice of effectiveness13 May 2025
  • EFFECTNotice of effectiveness16 Apr 2025
  • CT ORDERConfidential treatment order26 Feb 2025
  • EFFECTNotice of effectiveness26 Aug 2022
  • EFFECTNotice of effectiveness19 Jul 2021

Exempt Offerings(6)

Expand
  • DRule 506(b) provides a "safer harbor" for a private offering8 Oct
  • DRule 506(b) provides a "safer harbor" for a private offering6 Aug
  • DRule 506(b) provides a "safer harbor" for a private offering8 Jun
  • D06b5 Dec 2024
  • D06b27 Feb 2024
  • D06b19 Oct 2020

Other(3)

Expand
  • SEC STAFF LETTERSEC STAFF LETTER15 Jul 2021
  • CERTCERT15 Jul 2021
  • SEC STAFF LETTERSEC STAFF LETTER22 Jun 2021